Chronic opioid use is associated with obstructive and spastic disorders in the esophagus

• Published in: Neurogastroenterology and motility Vol. 34; no. 3; pp. e14233 - n/a
• Main Authors: Sanchez, Mayra J., Olivier, Sarah, Gediklioglu, Furkan, Almeida, Mariana, Gaeta, Marina, Nigro, Mariana, Rosa, Randolph, Nguyen, Mytien, Lalehzari, Mona, Regala, Francis, Njei, Basile, Deng, Yanhong, Ciarleglio, Maria, Masoud, Amir
• Format: Journal Article
• Language: English
• Published: England Wiley Subscription Services, Inc 01.03.2022
• Subjects: Achalasia; Analgesics, Opioid - adverse effects; Electronic medical records; Esophageal Achalasia; Esophageal diseases; esophageal motility; Esophageal Motility Disorders - chemically induced; Esophageal Motility Disorders - diagnosis; Esophageal Motility Disorders - epidemiology; Esophagogastric Junction; Esophagus; Gastric motility; high‐resolution manometry; Humans; Latency; Manometry - methods; Morphine; Motility; motility disorders; Muscle Spasticity - chemically induced; Narcotics; opioid; Opioid-Related Disorders; Opioids; Patients; Retrospective Studies; Spasticity; high-resolution manometry; esophageal motility; motility disorders; opioid
• ISSN: 1350-1925; 1365-2982
• DOI: 10.1111/nmo.14233

Background and Aims Chronic opioid effects on the esophagus are poorly understood. We investigated whether opioids were associated with increased prevalence of esophageal motility disorders. Methods A retrospective study of all patients undergoing high‐resolution manometry (HREM) at the Yale Gastrointestinal Motility Lab between January 2014 and August 2019. Data were extracted from the electronic medical record after studies were reviewed by two motility specialists using the Chicago Classification v.3.0. We compared the manometric results of patients who use opioids to those who do not and adjusted for type and dose of opioids using a 24 h Morphine Milligram Equivalents (MME) scale to compare patients taking low or high amounts of opioids. Results Four manometric abnormalities were significantly different between the opioid and non‐opioid users. Achalasia type III, esophagogastric junction outflow obstruction (EGJOO), and distal esophageal spasm (DES) (p < 0.005, p < 0.01, and p < 0.005, respectively) were common among opioid users, whereas ineffective esophageal motility (IEM) was more common among non‐opioid users (p < 0.01). The incidence of EGJOO was significantly higher in opioid users compared to non‐opioid users (p < 0.001). Lastly, IRP, DCI, and distal latency were significantly different between the two groups. Patients in the high MME group had significantly greater IRP, DCI, and lower distal latency than non‐opioids (p < 0.001). Also, achalasia type III and DES were more common in the high but not the low MME group. Conclusions Opioid use is associated with multiple abnormalities on esophageal motility and these effects may be dose‐dependent.